Projected Price to Earnings: Pulse Corp (PLSE)

PLSE (Pulse Biosciences, Inc.) - company brandmark

The expected P/E of Pulse Biosciences, Inc. (PLSE) reflects market expectations, while 0.00 records a new level. This price action correlates with Pulse Biosciences, Inc. (PLSE) partnerships with clinics to implement new medical standards. The business fundamentals rely on breakthrough NPS technology for the non-thermal destruction of neoplasms. Currently, the CellFX pipeline is reaching peak efficiency in the preparation of electrodes for ablation and fibrillation therapy.

pulsebiosciences.com - PLSE Market Cap to Future Earnings Ratio (period 07/04/2022 - 11/14/2026)

Metric breakdowns and analytics for Pulse Medical (PLSE)

- stock quotes and analyst forecast:
Stock Price Pulse Biosciences|PLSE - Average Forecast Price
- company stock exchange capitalization indicators:
Market Valuation Pulse Biosciences Inc|PLSE - Enterprise Value
- issuer book value statistics:
Accounting Value per Share Pulse Biosciences|PLSE - Total Net Assets|Market Capitalization to Book Value Ratio pulsebiosciences.com|PLSE - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital Pulse Biosciences, Inc.|PLSE - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Pulse Biosciences, Inc.|PLSE - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Pulse Biosciences Inc|PLSE - Company Long-Term Liabilities|Company Short-Term Debts Pulse Biosciences|Quick Ratio pulsebiosciences.com
- financial results and valuation multiples details:
PLSE - Company Profit|Projected Future Earnings Pulse Biosciences, Inc.|PLSE - Business Payback Period|Forward P/E Multiple Pulse Corp|PLSE - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Pulse Biosciences Inc|PLSE - Operating profit EBITDA|Earnings per share for the last twelve months Pulse Biosciences|PLSE - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months pulsebiosciences.com|PLSE - Earnings per share increase in current year|Earnings growth forecast for next year Pulse Biosciences, Inc.
- company sales and revenue statistics:
PLSE - Company Total Revenue|Company Projected Revenue Pulse Biosciences|PLSE - Price-to-Revenue Multiple|Forward Price-to-Revenue Multiple Pulse Biosciences Inc
Fundamental valuation:PLSE Pulse Biosciences
Brand item of pulsebiosciences.com

The development of ablation technologies at Pulse Biosciences, Inc. (PLSE) depends directly on clinical trial outcomes and market adoption. The company's forward 12-month P/E ratio reflects the asset's market value relative to projected net income. This metric is calculated by dividing the current share price by the expected earnings per share. The trend of this indicator allows for an assessment of the degree of overvaluation relative to future cash flows. Investors should interpret this chart as an indicator of the risk premium associated with the commercial launch.

Competitors of Pulse Biosciences, Inc.

Forward P/E Multiple DXCM|PEN - Projected Price to Earnings Ratio|Novanta Corp - Projected Price to Earnings|Forward P/E Multiple Haemonetics Company HAE|INSP: Projected Price to Earnings|procept-biorobotics.com - Market Cap to Future Earnings Ratio|CNMD: Forward P/E Multiple|INMD - Market Cap to Projected Earnings|PMI (Picard Medical Inc.) - Forward P/E Multiple|Projected Price to Earnings Surmodics Inc. (SRDX)|Projected Price to Earnings SENS (Senseonics)|NPCE (neuropace.com) - Future Price to Earnings Multiple|Future Price to Earnings Tactile Medical TCMD|SNWV - Projected Price to Earnings|Outset - Forward P/E Multiple|Projected Price to Earnings Ratio Electromed, Inc.|LNSR: Forward P/E Multiple|Price to Future Earnings Ratio RCEL|PROF (Profound Medical Corp) - Forward P/E Multiple|Baird Medical Corp (BDMD) - Market Cap to Projected Earnings|Forward P/E Multiple EDAP|Projected Price to Earnings apyxmedical.com APYX|Forward P/E Multiple ICCM (IceCure Medical)|Forward P/E Multiple Pulmonx Corp LUNG|TELA - Future Price to Earnings|CTSO: Future Price to Earnings|SRTS (Sensus Healthcare Corp) - Projected Price to Earnings|Zynex Corp - Future Price to Earnings Multiple|ECOR (electroCore Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio Vicarious Surgical Corp RBOT|Future Price to Earnings Inspira Technologies Oxy (IINN)|SeaStar Medical Holding Corporation (ICU) - Forward Price to Earnings Multiple|IRIDEX - Projected Price to Earnings|Forward P/E Multiple Intelligent Bio Solutions Inc INBS|AINostix - Forward P/E Multiple|Market Cap to Projected Earnings profusa.com PFSA|strataskinsciences.com (SSKN) - Future Price to Earnings|Price to Expected Earnings Ratio GCTK (glucotrack.com)|Future Price to Earnings NanoVibronix|Projected Price to Earnings Venus Concept Corporation (VERO)|Forward P/E Multiple NUWE|AEMD - Projected Price to Earnings Ratio|Future Price to Earnings Asensus Surgical ASXC|AVGR: Price to Future Earnings Ratio|BSGM: Projected Price to Earnings|Cutera Inc - Market Cap to Future Earnings Ratio|Know Labs, Inc. (KNW) - Future Price to Earnings|Price to Expected Earnings Ratio NARI (inarimedical.com)|Projected Price to Earnings NVRO|Forward P/E Multiple ReShape Lifesciences Inc|Future Price to Earnings Silk Road Medical Inc. (SILK)